Clinical implications of advanced molecular cytogenetics in cancer

References

• Kjeldsen E, Kolvaraa S. FISH technique, FISH probes and their applications in medicine and biology: an overview. In: FISH Technology Rautenstraufi B, Liehr T (Eds), Springer—Verlag, Berlin, Germany, 3–50 (2002).
   Google Scholar
• •Good overview of fluorescence in situ hybridization (FISH).
   Google Scholar
• Wang N. Methodologies in cancer cytogenetics and molecular cytogenetics. Am. Merl Genet. 115,118–124 (2002).
   PubMed Web of Science ®Google Scholar
• Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia. Nature 243,290–293 (1973).
   PubMed Web of Science ®Google Scholar
• Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D. Further evidence for a nonrandom chromosomal abnormality in acute promyelocytic leukemia. InLj Cancer20, 869–872 (1977).
   PubMed Web of Science ®Google Scholar
• Johansson B, Mertens F, Mitelman Primary vs. secondary neoplasia-associated chromosomal abnormalities: balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16,155–163 (1996).
   PubMed Web of Science ®Google Scholar
• Mitelman E Recurrent chromosome aberrations in cancer. Mutat. Res. 462, 247–253 (2000).
   Google Scholar
• Slominski A, Wortsman J, Carlson A et al Molecular pathology of soft tissue and bone tumors. Arch. Pallid Lab. Merl 123, 1246–1259 (1999).
   PubMed Web of Science ®Google Scholar
• Skapek SX, Chui CH. Cytogenetics and the biologic basis of sarcomas. CU17: Opin. Oncol 12,315–322 (2000).
   Google Scholar
• Cory S, Adams JM. The BCL2 family: regulators of the cellular life-or-death switch. Nature Rev. Cancer2, 647–656 (2002).
   Google Scholar
• Slupianek A, Hoser G, Majsterek I eta]. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G2/M phase and protection from apoptosis. Mal Cell Biol. 22,4189-4201(2002).
   Google Scholar
• Redner RL. Variations on a theme: the alternate translocations in APL. Leukemia 16,1927–1932(2002).
   PubMed Web of Science ®Google Scholar
• Namazie A, Alavi S, Olopade 01 eta]. Cyclin D1 amplification and p16 (WITS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112,472–481 (2002).
   Google Scholar
• Pelengaris S, Khan M, Evans GI. Suppression of myc-induced apoptosis in cells exposed to multiple oncogenic properties of myc and triggers carcinogenic progression. Cell 109, 321–334 (2002).
   Google Scholar
• Hallek M, Leif Bergsagel P, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91,3–21 (1998).
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau H, Facon T, Daviet A etal q 13 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for oncogenesis of multiple myeloma. Cancer Res. 59, 4546–4550 (1999).
   Google Scholar
• Harrison CJ, Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev. Clin. Exp. Hematol 6, 91–113 (2002).
   PubMedGoogle Scholar
• Jakic-Razumavic J, Aurer I. The World Health Organization classification of lymphomas. Croat. Med. 1). 43,527-534 (2002).
   Google Scholar
• •Advantage of FISH over PCR for detecting translocations within regions showing multiple and dispersed chromosomal breakpoints.
   Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100,2292–2302 (2002).
   Google Scholar
• Chen Z, Sandberg AA. Molecular cytogenetics aspects of hematological malignancies: clinical implications. Am. Med. Genet. 115,130–141 (2002).
   PubMed Web of Science ®Google Scholar
• Dewald GW. Interphase FISH studies of chronic myeloid leukemia. Methods Mal Biol. 204,311–342 (2002).
   PubMedGoogle Scholar
• •• Provides comparative perspective on different probe designs in light of clinical findings and highlights the advantages of interphase FISH over classic metaphase karyotyping in chronic myeloid leukemia (CML).
   Google Scholar
• Schoch C, Schnittger S, Bursch S eta]. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 16,53–59 (2002).
   Google Scholar
• Hernandez JM, Gonzalez MB, Grananda I eta]. Detection of inv (16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo. Hematologica 85, 481–485 (2000).
   Google Scholar
• Reddy KS, Parsons L, Mak L eta]. Segmental amplification of 11q23 region identified by fluorescence in situ hybridization in four patients with myeloid disorders. Cancer Genet. Cytogenet. 126, 139–146 (2001).
   Google Scholar
• Schnittger S, Kinkelin U, Schoch C etal Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 14,796–804 (2000).
   PubMed Web of Science ®Google Scholar
• Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. j Clin. Oncol 18, 3707–3721 (2000).
   PubMed Web of Science ®Google Scholar
• Bordeleau L, Berinstein NL. Molecular diagnostics in follicular non-Hodgkin's lymphoma. Semin. 017COI 27(6 Suppl. 12), 42–52 (2000).
   Google Scholar
• Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Ainj Athol 160,759–763 (2002).
   PubMed Web of Science ®Google Scholar
• Varella-Garcia M. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis and therapy. Oncologist 8,45–58 (2003).
   PubMed Web of Science ®Google Scholar
• Mitelman F, Jhansson B, Mandahl N, Mertens E Clinical significance of cytogenetics findings in solid tumors. Cancer Genet. Cytogenet. 95,1–8 (1997).
   PubMed Web of Science ®Google Scholar
• Cole P, Ladanyi M, Gerald WL etal Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis. Med. Pediatr Oncol 32,97–101 (1999).
   PubMedGoogle Scholar
• Singer S. New diagnostic modalities in soft tissue sarcoma. Semin. Surg. Oncol 17, 11–22 (1999).
   PubMedGoogle Scholar
• Maintz D, Fiedler K, Koopmann J etal Molecular genetic evidence for subtypes of oligoastrocytomas. I Neuropathol Exp. Neural 56,1098–1104 (1997).
   PubMed Web of Science ®Google Scholar
• Bullerdiek J, Wobst G, Meyer-Bolte K etal Cytogenetic subtyping of 220 salivary gland pleomorphic adnomas: correlation to occurrence, histologic subtype and in vitro cellular behavior. Cancer Genet. Cytogenet. 65,27-31 (1993).
   Google Scholar
• VOZ M, Agten NS, Van de Ven WJM, Kas K. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res. 60,106-113 (2000).
   Google Scholar
• Wessels PH, Hopman AHN, Ummelen MIJ etal Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization. Neurology56, 1224–1227 (2001).
   PubMed Web of Science ®Google Scholar
• Perry A, Kunz SN, Fuller CE etal Differential NF1, p16 and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. I Neuropathol Exp. Neural 61,702–709 (2002).
   Google Scholar
• Padua RA, McGlynn A, McGlynn H. Molecular, cytogenetics, and genetic abnormalities in MDS, and secondary AML. Myelo*plastic Syndromes and Secondary Acute IWelogenous Leukemia. Raza A, Mundle S (Eds), Kluwer, Dordrecht, The Netherlands, 111–158 (2001).
   Google Scholar
• Greenberg PL, Cox C, LeBeau MM etal International scoring system for evaluating prognosis in myelodysplastic syndromes. B/ooc/89,2079–2088 (1997).
   Google Scholar
• Döhner H, Stilgenbauer S, Benner A etal Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl. Med. 343,1910–1916 (2000).
   PubMed Web of Science ®Google Scholar
• •Extensive analysis of disease progression and prognosis in B-cell chronic lymphocytic leukemia patients in relation to different cytogenetic abnormalities.
   Google Scholar
• Fonseca R, Blood E, Rue M eta]. Clinical and biological implications of recurrent genomic aberrations in myeloma. B/ooc/101,4569–4575 (2003) .
   Google Scholar
• •Survival analysis of multiple myeloma patients in relation to different cytogenetic abnormalities.
   Google Scholar
• Masood S, Bui MM. Prognostic and predictive value of HERZ' neu oncogene in breast cancer. Microscopy Res. Tech. 59, 102–108 (2002).
   PubMed Web of Science ®Google Scholar
• ••Excellent review of clinical correlates ofHER2I neu amplification in breast cancer.
   Google Scholar
• Bennicelli JL, Barr FG. Chromosomal translocations and sarcomas. CI.117: Opin. Oncol 14,412–419 (2002).
   Google Scholar
• Miyamoto R, Uzawa N, Nagaoka S etal Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 95, 2152–2159 (2002).
   PubMed Web of Science ®Google Scholar
• Perry A, Fuller CE, Baneijee R etal Ancillary FISH analysis for lp and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Front. Blast". 8, A1—A9 (2003).
   Google Scholar
• CatiOrnagn0 C, Perrone F, Gallo C etal c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. j Clin. Oncol 14,2702–2708 (1996).
   Google Scholar
• Bianco AR, De Laurentiis M, Carlomagno C etal 20-year update of the Naples GUN trial of adjuvant breast cancer. Proc. Am. Soc. Clin. Oncol 17,373 (1998).
   Google Scholar
• Slamon D, Leyland-Jones B, Shak S etal Addition of Herceptin (humanized antiHER-2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer markedly increases anticancer activity: a randomized multinational controlled Phase III trial. Proc. Am. Soc. Clin. Oncol 17,377 (1998).
   Google Scholar
• Sauer T, Wiedswag G, Boudjema G, Christensen H, Karesen R. Assessment of HER2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? AP1Vff S111, 444–450 (2003).
   Google Scholar
• ••Detailed survival analysis and comparisonof FISH and immunohistochemistry for detection of HER2I neu amplification status.
   Google Scholar
• Grimwade D, Lo Coco FL. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia 16,1959–1973 (2002).
   PubMed Web of Science ®Google Scholar
• •Evaluation of therapeutic relevance of different chromosomal translocations in acute promyelocytic leukemia.
   Google Scholar
• Sarosdy NE, Schellhammer P, Bokinsky G et al Clinical evaluation of a multitarget fluorescent in situ hybridization assay for detection of bladder cancer. j Uml. 168, 1950–1954 (2002).
   Google Scholar
• Wang YL, Bagg A, Pear W, Nowell PC, Hess JL. Chronic myelogenous leukemia: laboratory diagnosis and monitoring. Genes Chromosomes Cancer 32,97–111 (2001).
   PubMed Web of Science ®Google Scholar
• ••Highlights FISH as the assay of choice inmonitoring minimal residual disease in patients with CML, especially following therapy with biological agents such as interferon-a and imatinib.
   Google Scholar
• Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetics response to interferon-alpha therapy. The Leukemia Service. Ann. Intern. Med 122,254–261 (1995).
   Google Scholar
• Druker BJ, Talpaz M, Resta D eta]. Clinical efficacy and safety of an ABL specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia. B/ooc/94(Suppl.), 368a (1999).
   Google Scholar
• Kearney L. The impact of the new FISH technologies on the cytogenetics of hematological malignancies. BE liaematol. 104,648–658 (1999).
   PubMed Web of Science ®Google Scholar
• Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60,3689–3695 (2000).
   PubMed Web of Science ®Google Scholar
• Sanchez-beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-celllymphoma. B/ooc/101,1220–1235 (2003).
   Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100, 57–70 (2000).
   PubMed Web of Science ®Google Scholar
• Cunningham MJ. Genomics and proteomics: the new millennium of drugdiscovery and development. j Pharmacol Toxicol Methods 44,291–300 (2000).
   PubMed Web of Science ®Google Scholar
• Hodgson G, Hager JH, Volik S et al Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nature Genet. 29,459–464 (2001).
   PubMed Web of Science ®Google Scholar
• Weber BL. Cancer genomics. Cancer Cell 1, 37–47 (2002).
   PubMed Web of Science ®Google Scholar
• Schubert CM. Microarray to be used as routine clinical screen. Nature Med. 9,9 (2003).
   PubMed Web of Science ®Google Scholar
• Phillips JL, Hayward SW Wang Y et al The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res. 61,8143–8149 (2001).
   PubMed Web of Science ®Google Scholar
• Hyman E, Kauraniemi P, Hautaniemi S etal Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62,6240–6245 (2002).
   PubMed Web of Science ®Google Scholar
• Pollack JR, Sorlie T, Perou CM et al Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Su USA 99, 12963–12968 (2002).
   PubMed Web of Science ®Google Scholar
• •Correlation of gene copy number gain/loss with the up/down-regulation of mRNA.
   Google Scholar
• Zhao J, Roth J, Bode-Lesniewska B etal. Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer 34,48–57 (2002).
   Google Scholar
• Hui AB, Lo KW, Yin XL, Poon WS, Ng HK. Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab. Invest. 81,717–723 (2001).
   Google Scholar
• Paris PL, Albertson DG, Alers JC etal High resolution analysis of paraffin embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am Pathol 162,763–770 (2003).
   PubMed Web of Science ®Google Scholar
• Mao X, Lillington D, Child F etal Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35,144–155 (2002).
   PubMed Web of Science ®Google Scholar
• Coon J, Ruffalo T, Kaiser K et al Microarray analysis of genomic changes in lung carcinomas. Proc. Am. Assoc. Clin. Res. (2003) (Abstract 3228).
   Google Scholar
• Veltman JA, Schoenmakers EFPM, Eussen BH etal High throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Arn. .1. Hum. Genet. 70,1269-1276 (2002).
   Google Scholar
• Harris NL, Stein H, Coupland SE eta]. New approaches to lymphoma diagnosis. Hematology (4m. Soc. Hematol Ecluc. Program) 194–220 (2001).
   Google Scholar
• ••Provides a very comprehensive view ofdifferent immunophenotypic, cytogenetics and molecular characteristics of different types of lymphoma.
   Google Scholar